FOTOTERAPIA NO PRURIDO RENAL E NO PRURIDO ASSOCIADO À INFECÇÃO PELO VIH
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2013 Introdução e Objectivos: A fototerapia (UVB isolados ou em combinação aos UVA) tem-se revelado eficaz no tratamento do prurido grave que complica, frequentemente, a doença renal crónica (DRC) ou a infecção pelo vírus da imunodeficiência humana (VIH ...
André Laureano +2 more
doaj +4 more sources
Tratamento sintomático em cuidados paliativos: Prurido
Revista Portuguesa de Medicina Geral e Familiar, 2003 O prurido é um sintoma que, apesar de aparentemente menos importante, pode afectar bastante a qualidade de vida de alguns doentes terminais. O manejo deste sintoma não se reduz apenas à utilização de anti-histamínicos, pelo que ao longo deste artigo ...
Luísa Carvalho
doaj +2 more sources
PRURIDO E ACHADOS DERMATOLÓGICOS EM PACIENTES EM HEMODIÁLISE
Clinical and Biomedical Research, 2020 Objetivo: Problemas dermatológicos são freqüentes em pacientes renais crônicos em hemodiálise. Dentre os mais comuns, destaca-se o prurido, que acomete entre 25 e 90% dessa população.
Marcelo Generali da Costa +4 more
doaj +1 more source
Pruritus: still a challenge Prurido: ainda um desafio
Anais Brasileiros de Dermatologia, 2012 Pruritus is a symptom that may be associated with a wide array of diseases - skin diseases, systemic diseases or even those without a defined cause. According to its severity and evolution, it may compromise the patients' quality of life in a significant
Paulo Rowilson Cunha +1 more
doaj +2 more sources
Prurido generalizado na gravidez: a propósito de um caso clínico.
Revista Portuguesa de Medicina Geral e Familiar, 2000 Relata-se o caso clínico de uma grávida que apresenta, em consulta de vigilância da gravidez, prurido generalizado às 35 semanas de gestação. Com base na história clínica e exame físico foram colocadas as seguintes hipóteses de diagnóstico: Colestase ...
Ana Veiga Macedo, Claúdia Marques
doaj +2 more sources
Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client-Owned Dogs: A Multicenter, Double-Masked, Randomised, Placebo-Controlled Clinical Trial. [PDF]
Vet DermatolBackground: Inhibition of the Janus kinase pathway is an established treatment for allergic dermatitis. Objective: To evaluate the efficacy and safety of ilunocitinib for control of pruritus in dogs with allergic dermatitis in a randomised, double‐masked clinical trial.
Forster S +5 more
europepmc +2 more sources
An open-label pilot study on an adsorbent mousse containing adelmidrol in client-owned cats with feline atopic skin syndrome and associated seborrhoea. [PDF]
Vet DermatolBackground – Besides pruritus and skin lesions, cats with feline atopic skin syndrome (FASS) may have seborrhoea. Hypothesis/Objectives – The aim of this pilot study was to investigate whether an adsorbent mousse containing tapioca starch, adelmidrol and a nonpharmacological antimicrobial complex could decrease FASS‐associated seborrhoea in cats ...
Noli C +4 more
europepmc +2 more sources
Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client-owned dogs: A multicentre, double-masked, randomised, placebo-controlled clinical trial. [PDF]
Vet DermatolBackground – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Forster S +5 more
europepmc +2 more sources
Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. [PDF]
Vet DermatolBackground – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Forster S +4 more
europepmc +2 more sources
Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study. [PDF]
Vet DermatolBackground: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Bizikova P +6 more
europepmc +2 more sources